Amla (Emblica officinalis Gaertn.)prevents dyslipidaemia and oxidative stress in the ageing process

British Journal of Nutrition

Volumn 97, Issue 6, 2007, Pages 1187-1195

  Yokozawa, Takako ^a   Kim, H Young ^a   Kim, H Ju ^a   Okubo, Tsutomu ^b   Chu, Djoing Chi ^b   Juneja, Lekh Raj ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b TAIYO KAGAKU CO LTD   (Japan)

Author keywords

Ageing; Amla; Dyslipidaemia; Oxidative stress

Indexed keywords

CHOLESTEROL; CYCLOOXYGENASE 2; EMBLICA OFFICINALIS EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPID; LIVER PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN BAX; PROTEIN BCL 2; SUNAMLA; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DRUG MECHANISM; DYSLIPIDEMIA; LIPID BLOOD LEVEL; LIPID METABOLISM; LIVER MITOCHONDRION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; TRANSCRIPTION REGULATION; TRIACYLGLYCEROL BLOOD LEVEL;

AGING; ANIMALS; ASCORBIC ACID; BODY WEIGHT; CHOLESTEROL; DYSLIPIDEMIAS; EATING; FLAVONOIDS; LIPID METABOLISM; LIVER; MALE; OXIDATIVE STRESS; PHENOLS; PHYLLANTHUS EMBLICA; PHYTOTHERAPY; PLANT EXTRACTS; PROTEINS; RATS; RATS, WISTAR; TRIGLYCERIDES;

PHYLLANTHUS EMBLICA; RATTUS;

EID: 34250372474     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507691971     Document Type: Article

References (60)

1. Anila L & Vijayalakshmi NR (2002) Flavonoids from Emblica officinalis and Mangifera indica - effectiveness for dyslipidemia. J Ethnopharmacol 79, 81-87.
2. Anila L & Vijayalakshmi NR (2003) Antioxidant action of flavonoids from Mangifera indica and Emblica officinalis in hypercholesterolemic rats. Food Chemistry 83, 569-574.
3. Asmawi MZ, Kankaanranta H, Moilanen E & Vapaatalo H (1993) Anti-inflammatory activities of Emblica officinalis Gaernt leaf extracts. J Pharm Pharmacol 45, 581-584.
4. Baldwin AS (2001) The transcription factor NF-κB and human disease. J Clin Invest 107, 3-6.
5. Bandyopadhyay SK, Pakrashi SC & Pakrashi A (2000) The role of antioxidant activity of Phyllanthus emblica fruits on prevention from indomethacin induced gastric ulcer. J Ethnopharmacol 70 171-176.
6. Barbier O, Torra P, Duguay Y, Blanquart C, Fruchart JC, Glineur C & Staels B (2002) Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol 22, 717-726.
7. Berkman KB & Ames BN (1998) The free radical theory of aging matures. Physiol Rev 78, 547-581.
8. Berger JP, Akiyama TE & Meinke PT (2OQ5) PPARs: Therapeutic targets for metabolic disease. Trends Pharmacol Sci 26, 244-251.
9. Bhattacharya A, Chatterjee A, Ghosal S & Bhattacharya SK (1999) Antioxidant activity of active tannoid principles of Emblica officinalis (amla). Indian J Exp Biol 37, 676-680.
10. Blanquart C, Barbier O, Fruchart JC, Staels B & Glineur C (2003) Peroxisome proliferator-activated receptors: Regulation of transcriptional activities and roles in inflammation. J Steroid Biochem Mol Biol 85, 267-273.
11. Buege JA & Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52, 302-306.
12. Chan SL & Yu VC (2004) Proteins of the bcl-2 family in apoptosis signalling: From mechanistic insights to therapeutic opportunities. Clin Exp Pharmacol Physiol 31, 119-128.
13. Choi YH, Lee SJ, Nguyen P, Jang JS, Lee J, Wu ML, Takano E, Maki M, Henkard PA & Trepel JB (1997) Regulation of cyclin D1 by calpain protease. J Biol Chem 272, 28479-28484.
14. De la Lastra, CA & Villegas I (2005) Resveratrol as an and-inflammatory and anti-aging agent: Mechanisms and clinical implications. Mol Nutr Food Res 49, 405-430.
15. Deokar AB (1998) Medicinal Plants Grown at Rajagaon, 1st ed., pp. 48-49, Pane: DS Manav Vikas Foundation.
16. El-Mekkawy S, Meselhy MR, Kusumoto, IT, Kadota, S, Hattori M & Namba, T (1995) Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. Chem Pharm Bull 43, 641-648.
17. Ferrari AU, Radaelli A & Centola M (2003) Aging and the cardiovascular system. J Appl Physiol 95, 2591-2597.
18. Folch J, Lees M & Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226, 497-509.
19. Ghosal S, Tripathi VK & Chauhan S (1996) Active constituents of Emblica officinalis: Part 1 - The chemistry and antioxidant effects of two new hydrolysable tannins, emblicanin A and B. Indian J Chem 35B, 941-948.
20. Green DR & Reed JC (1998) Mitochondria and apoptosis. Science 281, 1309-1312.
21. Halliwell B & Chirico S (1993) Lipid peroxidation: Its mechanism measurement and significance. Am J Clin Nutr 57, 715-725.
22. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL & Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251.
23. Inoue I, Noji S, Shen MZ, Takahashi K & Katayama S (1997) The peroxisome proliferator-activated receptor α (PPARα) regulates the plasma thiobarbituric acid-reactive substance (TBARS) level. Biochem Biophys Res Commun 237, 606-610.
24. Inoue I, Itoh F, Aoyagi S, et al. (2002) Fibrate and statin synergistically increase the transcriptional activities of PPARα/RXRα and decrease the transactivation of NFκB. Biochem Biophys Res Commun 290, 131-139.
25. Itzhaki RF & Gill DM (1964) A micro-biuret method for estimating proteins. Anal Biochem 9, 401-410.
26. Johnson D & Lardy H (1967) Isolation of liver or kidney mitochondria. Methods Enzymol X, 94-96.
27. Jose JK & Kuttan R (1995) Antioxidant activity of E. officinalis. J Clin Biochem Nutr 19, 63-70.
28. Jose JK, Kuttan G & Kuttan R (2001) Antitumour activity of Emblica officinalls. J Ethnopharmacol 75, 65-69.
29. Jung K & Pergande M (1985) Influence of cyclosporin A on the respiration of isolated rat kidney mitochondria. FEBS Lett 193, 167-169.
30. Kim CH, Park DH, Chung A, Zou Y, Jung KJ, Sung BK, Yu BP & Chung HY (2004) Proteomic analysis of post-mitochondrial fractions of young and old rat kidney. Exp Geront 39, 1155-1168.
31. Kim HJ, Yokozawa T, Kim HY, Tohda C, Rao TP & Juneja LR (2005) Influence of amla (Emblica officinalis Gaertn.) on hypercholesterolemia and lipid peroxidation in cholesterol-fed rats. J Nutr Sci Vitaminol 51, 413-418.
32. Kim HJ, Yu BP & Chung HY (2002) Molecular exploration of age-related NF-κB/IKK downregulation by calorie restriction in rat kidney. Free Radic Biol Med 32, 991-1005.
33. Knight JA (2001) The biochemistry of aging. Adv Clin Chem 35 1-62.
34. Lacko AG & Davis JL (1979) Age-related changes in rat and primate plasma cholesterol metabolism. J Am Geriatr Soc 5, 212-217.
35. Lavrovsky Y, Chatterjee B, Clark RA & Roy AK (2000) Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol 35, 521-532.
36. Li Q & Verma IM (2002) NF-κB regulation in the immune system. Nat Immunol 2, 725-734.
37. Lin MT & Beal MF (2003) The oxidative damage theory of aging. Clin Neurosci Res 2, 305-315.
38. Naito C & Yamanaka T (1978) Atherosclerotic disorder and lipid peroxidation. Jpn J Geriatr 15, 187-191.
39. Pahan K, Jana M, Liu X, Taylor BS, Wood C & Fischer SM (2002) Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric oxide synthase in human astrocytes. J Biol Chem 277, 45984-45991.
40. Parini P, Angelin B & Rudling M (1999) Cholesterol and lipoprotein metabolism in aging: Reversal of hypercholesterolemia by growth hormone treatment in old rats. Arterioscler Thromb Vasc Biol 19, 832-839.
41. Perry LM (1980) Medicinal Plants of East and South East Asia: Attributed Properties and Uses. Cambridge, MA: MIT Press.
42. Peters JM, Hennuyer N, Staels B, Fruchart JC, Fievet C, Gonzalez FJ & Auwerx J (1997) Alteration in lipoprotein metabolism in peroxisome proliferator-activated receptor-α deficient mice. J Biol Chem 272, 28307-28312.
43. Poon HF, Calabrese V, Scapagnini G & Butterfield DA (2004) Free radicals and brain aging. Clin Geriatr Med 20, 329-359.
44. Poynter ME & Daynes RA (1998) Peroxisome proliferator-activated receptor α activation modulates cellular redox status, represses nuclear factor-κB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem 273, 32833-32941.
45. Ricote M & Glass CK (2001) New roles fbf PPARs in cholesterol homeostasis. Trends Pharmacol Sci 22, 441-443.
46. Sabu MC & Kuttan R (2002) Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol 81, 155-160.
47. Sakurai H, Hisada Y, Ueno M, Sugiura M, Kawashima, K & Sugita T (1996) Activation of transcription factor NF-κB in experimental glomerulonephritis in rats. Biochim Biophys Acta 1316, 132-138.
48. Samhan-Arias AK, Martín-Romero FJ & Gutiérrez-Merino C (2004) Kaempferol blocks oxidative stress in cerebellar granule cells and reveals a key role for reactive oxygen species production at the plasm membrane in the commitment to apoptosis. Free Radic Biol Med 37 48-61.
49. Sanguino E, Ramón M, Michalik L, Wahli W, Alegret M, Sánchez RM, Vázquez-Carrera M & Laguna JC (2004a) Lack of hypotriglyceridemic effect of gemfibrozil as a consequence of age-related changes in rat liver PPARα. Biochem Pharmacol 67 157-166.
50. Sanguino E, Roglans N, Alegret M, Sánchez RM, Vázquez-Carrera M & Laguna JC (2004b) Prevention of age-related changes in rat cortex transcription factor activator protein-1 by hypolipidemic drugs. Biochem Pharmacol 68, 1411-1421.
51. Sanguino E, Roglans N, Alegret K Sánchez RM, Vázquez-Carrera M & Laguna JC (2005) Atorvastatin reverses age-related reduction in rat hepatic PPARα and HNF-4. Br J Pharmacol 145, 853-861.
52. Spencer NF, Poynter ME, Im SY & Daynes,RA (1997) Constitutive activation of NF-κB in an animal model of aging. Int Immunol 9, 1581-1588.
53. Thakur CP (1985) Emblica officinalis reduces serum, aortic and hepatic cholesterol in rabbits. Experientia 41, 423-424.
54. Toth MJ & Tehernof A (2000) Lipid metabolism in the elderly. Eur J Clin Nutr 54, S121-S125.
55. Wickens AP (2001) Ageing and the free radical theory, Respir Physiol 128, 379-391.
56. Williams RJ, Spencer JPE & Rice-Evans C (2004) Flavonoids: Antioxidants or signaligg molecule? Free Radic Biol Med 36, 838-849.
57. Yoon SO, Yun CH & Chung AS (2002) Dose effect of oxidative stress on signal transduction in aging. Mech Ageing Dev 123, 1597-1604.
58. Yu BP & Chung HY (2001) Oxidative stress and vascular aging. Diabetes Res Clin Pract 54, S73-S80.
59. Yu BP & Chung HY (2006) Adaptive mechanisms to oxidative stress during aging. Mech Ageing Dev 127, 436-443.
60. Zhang YJ, Tanaka T, Yang CR & Kouno I (2001) New phenolic constituents from the fruit juice Phyllanthus emblica. Chem Pharm Bull 49 537-540.